MedTrace Logo

Improving the Understanding of Catatonia in Autism

NCT02945423 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-04-10

No results posted yet for this study

Summary

Catatonia is a neuropsychiatric syndrome which is frequently missed or misdiagnosed among psychiatric patients. The current project is a systematic examination of catatonia which will characterize the phenotype and identify biological correlates that play a central role in the pathophysiology and effective pharmacological treatment of this condition.

Conditions

  • Autistic Disorder
  • Catatonia

Sponsors & Collaborators

Principal Investigators

  • Neera Ghaziuddin, M.D. · University of Michigan

Eligibility

Min Age
10 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-31
Primary Completion
2021-10-31
Completion
2023-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945423 on ClinicalTrials.gov